Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection

The purpose of this study was to investigate the quality of hydroxyprogesterone caproate (HPC) active pharmaceutical ingredient (API) sources that may be used by compounding pharmacies, compared to the FDA-approved source of the API; and to investigate the quality of HPC injection samples obtained f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chollet, John L., Jozwiakowski, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399637/
https://www.ncbi.nlm.nih.gov/pubmed/22329865
http://dx.doi.org/10.3109/03639045.2012.662511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399637/
https://www.ncbi.nlm.nih.gov/pubmed/22329865
http://dx.doi.org/10.3109/03639045.2012.662511

Ejemplares similares